Accelerated aging in major depression: The role of nitro-oxidative stress

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Luca, Maria ^a   Luca, Antonina ^a   Calandra, Carmela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; HEALTH CARE; MEDICINE;

ACCELERATED AGING; ANTI-INFLAMMATORIES; ANTIOXIDANT DEFENSE SYSTEM; MAJOR DEPRESSIONS; NEURODEGENERATION; NEURODEGENERATIVE DISORDERS; PREMATURE MORTALITY; THERAPEUTIC TOOLS;

NEURODEGENERATIVE DISEASES;

ANTIDEPRESSANT AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; ESCITALOPRAM; FOLIC ACID; MITOCHONDRIAL DNA; NEUROPROTECTIVE AGENT; OMEGA 3 FATTY ACID;

AGING; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; COGNITION; DEMENTIA; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EXECUTIVE FUNCTION; GENE EXPRESSION; GENETIC VARIABILITY; HISTONE MODIFICATION; HUMAN; LONGEVITY; MAJOR DEPRESSION; MOLECULAR INTERACTION; MONOAMINERGIC SYSTEM; NERVE CELL; NERVE DEGENERATION; NEUROPHYSIOLOGY; NEUROPROTECTION; NITROOXIDATIVE STRESS; NITROSATIVE STRESS; NITROSYLATION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PREMATURE MORTALITY; RESPIRATORY FUNCTION; REVIEW; TELOMERE; WORKING MEMORY; NITROSATION; PATHOLOGY;

AGING; DEPRESSIVE DISORDER, MAJOR; HUMANS; NERVE DEGENERATION; NITROSATION; OXIDATIVE STRESS;

EID: 84890077717     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/230797     Document Type: Review

References (70)

1. Thannickal V. J., Fanburg B. L., Reactive oxygen species in cell signaling. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2000 279 6 L1005 L1028 2-s2.0-0034533082 (Pubitemid 32009487)
2. Bolisetty S., Jaimes E. A., Mitochondria and reactive oxygen species: physiology and pathophysiology. International Journal of Molecular Sciences 2013 14 3 6306 6344 10.3390/ijms14036306
3. Baran C. P., Zeigler M. M., Tridandapani S., Marsh C. B., The role of ROS and RNS in regulating life and death of blood monocytes. Current Pharmaceutical Design 2004 10 8 855 866 2-s2.0-1642286961 10.2174/1381612043452866 (Pubitemid 38380064)
4. Gella A., Durany N., Oxidative stress in Alzheimer disease. Cell Adhesion and Migration 2009 3 1 88 93 2-s2.0-67049134478 10.4161/cam.3.1.7402
5. Ogino K., Wang D. H., Biomarkers of oxidative/nitrosative stress: an approach to disease prevention. Acta Medica Okayama 2007 61 4 181 189 2-s2.0-34848827135 (Pubitemid 47502130)
6. Klandorf H., van Dyke K., Lushchak V., Oxidative and nitrosative stresses: their role in health and disease in man and birds. Oxidative Stress-Molecular Mechanisms and Biological Effects 2012 chapter 3 Rijeka, Croatia InTech 10.5772/33879
7. Khassaf M., McArdle A., Esanu C., Vasilaki A., McArdle F., Griffiths R. D., Brodie D. A., Jackson M. J., Effect of vitamin C supplements on antioxidant defence and stress proteins in human lymphocytes and skeletal muscle. Journal of Physiology 2003 549 2 645 652 2-s2.0-0037834474 (Pubitemid 36701774)
8. Fiedorowicz M., Grieb P., Gonzalez-Quevedo A., Nitrooxidative stress and neurodegeneration. Brain Damage-Bridging Between Basic Research and Clinics 2012 chapter 6 Rijeka, Croatia InTech 10.5772/37733
9. Ljubuncic P., Gochman E., Reznick A. Z., Bondy S., Maiese K., Nitrosative stress in aging-its importance and biological implications in NF- B signaling. Aging and Age-Related Disorders, 2010 Springer Science+Business Media, LLC Oxidative Stress in Applied Basic Research and Clinical Practice 3
10. Kregel K. C., Zhang H. J., An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007 292 1 R18 R36 2-s2.0-33846243745 10.1152/ajpregu.00327.2006 (Pubitemid 46091599)
11. Nakamura T., Cho D. H., Lipton S. A., Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Experimental Neurology 2012 238 1 12 21 10.1016/j.expneurol.2012.06.032
12. Morawe T., Hiebel C., Kern A., Behl C., Protein homeostasis, aging and Alzheimer's disease. Molecular Neurobiology 2012 46 1 41 54 2-s2.0-84857227341 10.1007/s12035-012-8246-0
13. Gemma C., Vila J., Bachstetter A., Bickford P. C., Riddle D. R., Oxidative stress and the aging brain: from theory to prevention. Brain Aging: Models, Methods, and Mechanisms 2007 chapter 15 Boca Raton, Fla, USA CRC Press. http://www.ncbi.nlm.nih.gov/books/NBK3869/
14. Lu T., Pan Y., Kao S. Y., Li C., Kohane I., Chan J., Yankner B. A., Gene regulation and DNA damage in the ageing human brain. Nature 2004 429 6994 883 891 2-s2.0-3042631024 10.1038/nature02661 (Pubitemid 38843301)
15. Corral-Debrinski M., Horton T., Lott M. T., Shoffner J. M., Beal M. F., Wallace D. C., Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genetics 1992 2 4 324 329 2-s2.0-0027017232
16. Yehuda S., Rabinovitz S., Carasso R. L., Mostofsky D. I., The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiology of Aging 2002 23 5 843 853 2-s2.0-0036752552 10.1016/S0197-4580(02) 00074-X (Pubitemid 35217710)
17. Luo X. G., Ding J. Q., Chen S. D., Microglia in the aging brain: relevance to neurodegeneration. Molecular Neurodegeneration 2010 5 1, article 12 2-s2.0-77950826971 10.1186/1750-1326-5-12
18. Lagouge M., Larsson N. G., The role of mitochondrial DNA mutations and free radicals in disease and ageing. Journal of Internal Medicine 2013 273 6 529 543 10.1111/joim.12055
19. Lee H. C., Wei Y. H., Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Experimental Biology and Medicine 2007 232 5 592 606 2-s2.0-34247623639
20. Cencioni C., Spallotta F., Martelli F., Oxidative stress and epigenetic regulation in ageing and age-related diseases. International Journal of Molecular Sciences 2013 14 9 17643 17663 10.3390/ijms140917643
21. Mattson M. P., Camandola S., NF- B in neuronal plasticity and neurodegenerative disorders. Journal of Clinical Investigation 2001 107 3 247 254 2-s2.0-0034746288
22. Calabrese V., Cornelius C., Leso V., Trovato-Salinaro A., Ventimiglia B., Cavallaro M., Scuto M., Rizza S., Zanoli L., Neri S., Castellino P., Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochimica et Biophysica Acta 2012 1822 5 729 736 2-s2.0-84858152480 10.1016/j.bbadis.2011.12.003
23. Peluso I., Morabito G., Urban L., Ioannone F., Serafini M., Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocrine, Metabolic and Immune Disorders-Drug Targets 2012 12 4 351 360 10.2174/187153012803832602
24. Ng F., Berk M., Dean O., Bush A. I., Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. International Journal of Neuropsychopharmacology 2008 11 6 851 876 2-s2.0-50849139232 10.1017/S1461145707008401
25. Seven A., Aslan M., Incir S., Altntaş A., Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy. Folia Neuropathologica 2013 51 1 58 64
26. Butterfield D. A., Castegna A., Drake J., Scapagnini G., Calabrese V., Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutritional Neuroscience 2002 5 4 229 239 2-s2.0-0035988588 10.1080/ 10284150290028954 (Pubitemid 34823459)
27. Mancuso C., Scapagnini G., Currò D., Giuffrida Stella A. M., De Marco C., Butterfield D. A., Calabrese V., Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Frontiers in Bioscience 2007 12 3 1107 1123 2-s2.0-34248187134 10.2741/2130 (Pubitemid 46846882)
28. Luca M., Prossimo G., Messina V., Luca A., Romeo S., Calandra C., Epidemiology and treatment of mood disorders in a day hospital setting from 1996 to 2007: an Italian study. Neuropsychiatric Disease and Treatment 2013 9 169 176
29. Bromet E., Andrade L. H., Hwang I., Sampson N. A., Alonso J., de Girolamo G., de Graaf R., Demyttenaere K., Hu C., Iwata N., Karam A. N., Kaur J., Kostyuchenko S., Lépine J., Levinson D., Matschinger H., Mora M. E. M., Browne M. O., Posada-Villa J., Viana M. C., Williams D. R., Kessler R. C., Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine 2011 9, article 90 2-s2.0-79960659664 10.1186/1741-7015-9-90
30. Wolkowitz O. M., Mellon S. H., Epel E. S., Lin J., Dhabhar F. S., Su Y., Reus V. I., Rosser R., Burke H. M., Kupferman E., Compagnone M., Nelson J. C., Blackburn E. H., Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS ONE 2011 6 3 2-s2.0-79952964129 10.1371/journal.pone.0017837 e17837
31. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. Journal of Affective Disorders 2010 125 1-3 287 294 2-s2.0-77955556964 10.1016/j.jad.2009.12.014
32. Ravnkilde B., Videbech P., Clemmensen K., Egander A., Rasmussen N. A., Rosenberg R., Cognitive deficits in major depression. Scandinavian Journal of Psychology 2002 43 3 239 251 2-s2.0-0036634522 10.1111/1467-9450.00292
33. Marazziti D., Consoli G., Picchetti M., Carlini M., Faravelli L., Cognitive impairment in major depression. European Journal of Pharmacology 2010 626 1 83 86 2-s2.0-70849118227 10.1016/j.ejphar.2009.08.046
34. Richly P., Abdulhamid P., Bustin J., Depressive pseudodementia. Differential diagnosis or meeting point? Vertex 2012 23 106 421 427
35. Michel T. M., Pülschen D., Thome J., The role of oxidative stress in depressive disorders. Current Pharmaceutical Design 2012 18 36 5890 5899 10.2174/138161212803523554
36. Ozalay O., Calli C., Kitis O., Eker M. C., Eker O. D., Ozan E., Coburn K., Gonul A. S., The relationship between the anterior corpus callosum size and prefrontal cortex volume in drug-free depressed patients. Journal of Affective Disorders 2013 146 2 281 285 10.1016/j.jad.2012.06.040
37. Rajkowska G., Cell pathology in mood disorders. Seminars in Clinical Neuropsychiatry 2002 7 4 281 292 2-s2.0-0036782251
38. Orosz A., Jann K., Federspiel A., Horn H., Höfle O., Dierks T., Wiest R., Strik W., Müller T., Walther S., Reduced cerebral blood flow within the default-mode network and within total gray matter in major depression. Brain Connect 2012 2 6 303 310 10.1089/brain.2012.0101
39. Johnson A. W., Jaaro-Peled H., Shahani N., Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness. Proceedings of the National Academy of Sciences of the United States of America 2013 110 30 12462 12467
40. Fukui K., Omoi N. O., Hayasaka T., Shinnkai T., Suzuki S., Abe K., Urano S., Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Annals of the New York Academy of Sciences 2002 959 275 284 2-s2.0-0036240260 (Pubitemid 34457568)
41. Berr C., Balansard B., Arnaud J., Roussel A. M., Alpérovitch A., Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel. Journal of the American Geriatrics Society 2000 48 10 1285 1291
42. Maes M., de Vos N., Pioli R., Demedts P., Wauters A., Neels H., Christophe A., Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. Journal of Affective Disorders 2000 58 3 241 246 2-s2.0-0034106884 10.1016/S0165-0327(99)00121-4 (Pubitemid 30232781)
43. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M., The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 2009 24 1 27 53 2-s2.0-57749179191 10.1007/s11011-008-9118-1
44. Maes M., Galecki P., Chang Y. S., Berk M., A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 3 676 692 2-s2.0-79954568978 10.1016/j.pnpbp.2010.05.004
45. Tobe E. H., Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatric Disease and Treatment 2013 9 567 573
46. Jou S. H., Chiu N. Y., Liu C. S., Mitochondrial dysfunction and psychiatric disorders. Chang Gung Medical Journal 2009 32 4 370 379 2-s2.0-70349190515
47. Anglin R. E., Garside S. L., Tarnopolsky M. A., Mazurek M. F., Rosebush P. I., The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. Journal of Clinical Psychiatry 2012 73 4 506 512 2-s2.0-84860594239 10.4088/JCP.11r07237
48. McNamara R. K., Liu Y., Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. Journal of Affective Disorders 2011 129 1-3 359 363 2-s2.0-79851516186 10.1016/j.jad.2010.08.021
49. Hamazaki K., Hamazaki T., Inadera H., Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder. Journal of Psychiatric Research 2012 46 8 1024 1028 2-s2.0-84860574022 10.1016/j.jpsychires.2012.04.012
50. Raedler T. J., Inflammatory mechanisms in major depressive disorder. Current Opinion in Psychiatry 2011 24 6 519 525 2-s2.0-80053385511 10.1097/YCO.0b013e32834b9db6
51. Nunes S. O., Vargas H. O., Prado E., Barbosa D. S., de Melo L. P., Moylan S., Dodd S., Berk M., The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neuroscience and Biobehavioral Reviews 2013 37 8 1336 1345 10.1016/j.neubiorev.2013.04.014
52. Luca M., Luca A., Celia A., Calandra C., Prostaglandins pathway as a possible biological link between cancer and major depression. Bioactive Lipids in Cancer. In press
53. Leonard B. E., Inflammation, depression and dementia: are they connected? Neurochemical Research 2007 32 10 1749 1756 2-s2.0-34548809845 10.1007/s11064-007-9385-y (Pubitemid 47428863)
54. Bewernick B. H., Schlaepfer T. E., Chronic depression as a model disease for cerebral aging. Dialogues in Clinical Neuroscience 2013 15 1 77 85
55. Wolkowitz O. M., Reus V. I., Mellon S. H., Of sound mind and body: depression, disease, and accelerated aging. Dialogues in Clinical Neuroscience 2011 13 1 25 39 2-s2.0-79955826399
56. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuroendocrinology Letters 2009 30 6 715 722 2-s2.0-77649266722
57. Douillard-Guilloux G., Guilloux J. P., Lewis D. A., Sibille E., Anticipated brain molecular aging in major depression. The American Journal of Geriatric Psychiatry 2013 21 5 450 460 10.1016/j.jagp.2013.01.040
58. Sibille E., Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders. Dialogues in Clinical Neuroscience 2013 15 1 53 65
59. Kinser P. A., Lyon D. E., Major depressive disorder and measures of cellular aging: an integrative review. Nursing Research and Practice 2013 2013 10 469070 10.1155/2013/469070
60. Wikgren M., Maripuu M., Karlsson T., Nordfjll K., Bergdahl J., Hultdin J., Del-Favero J., Roos G., Nilsson L., Adolfsson R., Norrback K., Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biological Psychiatry 2012 71 4 294 300 2-s2.0-84856019753 10.1016/j.biopsych.2011.09.015
61. Blackburn E. H., Telomere states and cell fates. Nature 2000 408 6808 53 56 2-s2.0-0034597794 10.1038/35040500
62. Young L. T., Neuroprotective effects of antidepressant and mood stabilizing drugs. Journal of Psychiatry and Neuroscience 2002 27 1 8 9 2-s2.0-0036247091 (Pubitemid 34478365)
63. Hashioka S., McGeer P. L., Monji A., Kanba S., Anti-inflammatory effects of antidepressants: possibilities for preventives against alzheimer's disease. Central Nervous System Agents in Medicinal Chemistry 2009 9 1 12 19 2-s2.0-62549093608 10.2174/187152409787601897
64. Nibuya M., Morinobu S., Duman R. S., Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 1995 15 11 7539 7547 2-s2.0-0028815653
65. Lee C. H., Park J. H., Yoo K. Y., Choi J. H., Hwang I. K., Ryu P. D., Kim D., Kwon Y., Kim Y., Won M., Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress. Experimental Neurology 2011 229 2 450 459 2-s2.0-79956155995 10.1016/j.expneurol.2011.03.015
66. Smaga I., Pomierny B., Krzyżanowska W., Pomierny-Chamiolo L., Miszkiel J., Niedzielska E., Ogórka A., Filip M., N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats. Progress in Neuro- Psychopharmacology and Biological Psychiatry 2012 39 2 280 287 10.1016/j.pnpbp.2012.06.018
67. Jesse C. R., Wilhelm E. A., Bortolatto C. F., Nogueira C. W., Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010 34 2 294 302 2-s2.0-77649276066 10.1016/j.pnpbp.2009.11.023
68. Gerzson M. F. B., Victoria F. N., Radatz C. S., de Gomes M. G., Boeira S. P., Jacob R. G., Alves D., Jesse C. R., Savegnago L., In vitro antioxidant activity and in vivo antidepressant-like effect of (phenylselanyl) acetophenone in mice. Pharmacology Biochemistry and Behavior 2012 102 1 21 29 2-s2.0-84859638621 10.1016/j.pbb.2012.03.016
69. Mazza M., Pomponi M., Janiri L., Bria P., Mazza S., Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 31 1 12 26 2-s2.0-33845601611 10.1016/j.pnpbp.2006.07.010 (Pubitemid 44959258)
70. Budni J., Zomkowski A. D., Engel D., Santos D. B., dos Santos A. A., Moretti M., Valvassori S. S., Ornell F., Quevedo J., Farina M., Rodrigues A. L., Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Experimental Neurology 2013 240 112 121 10.1016/j.expneurol.2012.10.024